Copyright Reports & Markets. All rights reserved.

Europe Rotavirus Vaccine Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Rotavirus Vaccine Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Pentavalent Oral Market Performance (Volume)
      • 2.1.2 Oral Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Pentavalent Oral Market Performance (Value)
      • 2.1.2 Oral Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Government Institution Market Performance (Volume)
      • 3.1.2 Private Sector Market Performance (Volume)
      • 3.1.3 Other Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Astellas Pharma
      • 4.1.1 Astellas Pharma Profiles
      • 4.1.2 Astellas Pharma Product Information
      • 4.1.3 Astellas Pharma Rotavirus Vaccine Business Performance
      • 4.1.4 Astellas Pharma Rotavirus Vaccine Business Development and Market Status
    • 4.2 CSL Limited
      • 4.2.1 CSL Limited Profiles
      • 4.2.2 CSL Limited Product Information
      • 4.2.3 CSL Limited Rotavirus Vaccine Business Performance
      • 4.2.4 CSL Limited Rotavirus Vaccine Business Development and Market Status
    • 4.3 Emergent BioSolutions
      • 4.3.1 Emergent BioSolutions Profiles
      • 4.3.2 Emergent BioSolutions Product Information
      • 4.3.3 Emergent BioSolutions Rotavirus Vaccine Business Performance
      • 4.3.4 Emergent BioSolutions Rotavirus Vaccine Business Development and Market Status
    • 4.4 GlaxoSmithKline
      • 4.4.1 GlaxoSmithKline Profiles
      • 4.4.2 GlaxoSmithKline Product Information
      • 4.4.3 GlaxoSmithKline Rotavirus Vaccine Business Performance
      • 4.4.4 GlaxoSmithKline Rotavirus Vaccine Business Development and Market Status
    • 4.5 Johnson&Johnson
      • 4.5.1 Johnson&Johnson Profiles
      • 4.5.2 Johnson&Johnson Product Information
      • 4.5.3 Johnson&Johnson Rotavirus Vaccine Business Performance
      • 4.5.4 Johnson&Johnson Rotavirus Vaccine Business Development and Market Status
    • 4.6 MedImmune
      • 4.6.1 MedImmune Profiles
      • 4.6.2 MedImmune Product Information
      • 4.6.3 MedImmune Rotavirus Vaccine Business Performance
      • 4.6.4 MedImmune Rotavirus Vaccine Business Development and Market Status
    • 4.7 Merck
      • 4.7.1 Merck Profiles
      • 4.7.2 Merck Product Information
      • 4.7.3 Merck Rotavirus Vaccine Business Performance
      • 4.7.4 Merck Rotavirus Vaccine Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Rotavirus Vaccine Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Rotavirus Vaccine Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Rotavirus Vaccine Market Performance (Sales Point)

    • 7.1 Europe Rotavirus Vaccine Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Rotavirus Vaccine Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Rotavirus Vaccine Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Rotavirus Vaccine Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Government Institution Industry
    • 11.2 Private Sector Industry
    • 11.3 Other Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Rotavirus Vaccine Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Pentavalent Oral Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Oral Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Government Institution Sales and and Growth Rate 2019-2024
      • 12.4.3 Private Sector Sales and and Growth Rate 2019-2024
      • 12.4.4 Other Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Rotavirus Vaccine Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Rotavirus Vaccine Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Rotavirus Vaccine for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Rotavirus Vaccine market competition by top manufacturers/players, with Rotavirus Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma
    CSL Limited
    Emergent BioSolutions
    GlaxoSmithKline
    Johnson&Johnson
    MedImmune
    Merck
    ...

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Pentavalent Oral
    Oral

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rotavirus Vaccine for each application, including
    Government Institution
    Private Sector
    Other

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now